In addition to this, the piezo1 agonist Yoda1 + TRAIL can successfully kill glioblastoma cells that are particularly resistant to current standard therapies by activating piezo1, providing a new idea for the treatment of glioblastoma resistant to temozolomide. The gene discussed is PIEZO1; the disease is glioblastoma.